Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC1742 Dequalinium Bromide

HIV-1 fusion inhibitor, targeting the membrane-proximal external region of Env spikes, specifically inhibiting the HIV-1 envelope-mediated membrane fusion by blocking CD4-induced conformational changes

6707-58-0
DCC1743 Deramciclane Fumarate

Inhibitor of acetyl-CoA carboxylase (ACC), activating GPR40, inhibiting West Nile virus (WNV) infection and reducing the multiplication of Usutu virus (USUV), a WNV-related flavivirus

120444-72-6
DCC1744 Desfluoro Ezetimibe

Desfluoro impurity of Ezetimibe

302781-98-2
DCC1745 Desmethyl Mk-6884

Precursor for PET imaging 11C-radiolabeled MK-6884

DCC1746 Desmethyldiazepam

Primary metabolite of diazepam, binding to the GABA A receptor benzodiazepine modulatory site

1088-11-5
DCC1747 Desmethyl-hd-800

PET precursor of preparing radiolabel [11C]HD-800, a high affinity brain penetrant PET tracer for imaging microtubules

DCC1748 Desthiobiotin Polyethyleneoxide Iodoacetamide

Cysteine reactive protein labeling agent

DCC1749 Dexamethasone 21-phosphate Disodium

Pro-drug of dexamethasone, anti-inflammatory glucocorticoid, stimulating glutamine uptake in the cerebral cortex

55203-24-2
DCC1750 Dexamethasone Beloxil

Glucocorticoid, Anti-inflammatory Agent

150587-07-8
DCC1751 Dexloxiglumide

Cholecystokinin antagonist, selective for the CCKA subtype

119817-90-2
DCC1752 Dexmethylphenidate Hydrochloride

Norepinephrine-dopamine reuptake inhibitor (NDRI)

19262-68-1
DCC1753 Dezocine

Natural modulator of mu-, delta-, and kappa-opioid receptors

53648-55-8
DCC1754 Df-1012

5-HT3 Receptor antagonist; Antitussive; Anti-inflammatory; Antiasthmatic

163220-65-3
DCC1755 Df-461

Potent Squalene Synthase Inhibitor

927051-40-6
DCC1756 Dfk167

Cell-permeable, reversible and selective inhibitor of ɣ-secretase

200810-93-1
DCC1757 Dfkbp-2

Proteolysis targeting chimeras (PROTAC), potently decreasing FKBP12 abundance in MV4;11 cells, leading to over 80% reduction of FKBP12 at 0.1 μM and 50% reduction at 0.01 μM

DCC1758 Dg-051

Novel potent, orally active inhibitor of LTA4H

929916-05-2
DCC1759 dgat2 Inhibitor 122

Selective inhibitor of diacylglycerol acyltransferase 2 (DGAT2)

620931-38-6
DCC1760 Dg-c8-phip

The major adduct formed by the food-borne carcinogen, PhIP with DNA

142784-25-6
DCC1761 Dgj-pfpht

Novel human α-galactosidase A ligand, capable of stabilizing α-Gal A and restoring trafficking

1609458-32-3
DCC1762 Dgts(16:0/16:0)

Abundant lipid in the membranes of many algae, lower plants, and fungi, showing an inverse concentration relationship with phosphatidylcholine, being capable of replacing phosphatidylcholine

1607456-57-4
DCC1763 Dgy-08-097

Novel HCV NS3 degrader, reducing susceptibility to resistance mutations, potently inhibiting HCV in a cellular infection model, exhibiting the most potent degradation (DC50 of 50nM at 4h) of HCV NS3,

Page 1301 / Total 1557 FirstPrevNextLastGoto